RESUMO
Objective: To compare the effectiveness of perioperative vaginal misoprostol with intraoperative pericervical hemostatic tourniquet in reducing blood loss during abdominal myomectomy. Material and Methods: A randomized controlled trial involving women with uterine leiomyoma who underwent abdominal myomectomy was conducted at a tertiary facility in Nigeria. Participants were recruited after they gave informed consent and randomized into group I (single dose 400 µg vaginal misoprostol one-hour before surgery) and group II (intraoperative pericervical hemostatic tourniquet). Eighty participants (40 in each group) were recruited. Uterine size was measured in centimeters above the pubic symphysis, and blood loss estimation involved direct volume measurement and gravimetric methods. The main outcome measures were intraoperative blood loss, blood transfusion, and recourse to hysterectomy. Ethical approval and trial registration were obtained; the data were analyzed using the SPSS software version 21.0; p<0.05 was considered significant. Results: Participants in group I had higher mean intraoperative blood loss (931.89±602.13 vs 848.40±588.85 mL, p=0.532), intra-operative blood transfusion rates (60 vs 55%; p=0.651) and mean units of blood transfused (1.30±1.20 vs 1.20±1.30; p=0.722) compared with group II. The mean uterine size (19.50±6.93 vs 20.05±6.98 cm; p=0.725) and number of fibroid nodules (11.25±7.99 vs 11.45±8.22; p=0.912) were comparable. The change in post-operative hematocrit was 2.66±2.21% vs 3.24±2.85% (p=0.315) and post-operation blood transfusion was 2.5 vs 5% (p=0.556). There was no recourse to hysterectomy in either of the study groups. While adverse effects of misoprostol occurred in 5 (12.5%) participants of group I. Conclusion: The effectiveness of perioperative vaginal misoprostol is comparable to intra-operative hemostatic pericervical tourniquet in reducing blood loss during abdominal myomectomy.
RESUMO
To study the simultaneous variations of end-tidal CO2 pressure (PetCO2) and aortic blood flow (ABF) during modifications of tissue perfusion, continuous noninvasive hemodynamic monitoring and continuous recording of PetCO2 were performed on 30 patients under general anesthesia and artificial mechanical ventilation. The 30 patients underwent orthopedic surgery on one of the lower limbs using a hemostatic tourniquet. Deflation of the pneumatic tourniquet resulted in a rise of ABF up to 39% (P<0.001), a rise of PetCO2 up to 17% (P<0.001), and a drop of total vascular systemic resistance (TVSR) of 59% (P<0.001). In all cases, the gradient of Paco2-PetCO2 showed mean variations of 1.2±0.5 mmHg. According to these results, the observed variations can not be explained by an alteration of the Ventilation/Perfusion (Vo/Q) ratio alone. It may be suggested that tissue hypoperfusion produced by a tourniquet generates CO2 and other metabolic products accumulation in tissues, which are removed during reperfusion. This would be expected to produce parallel increases in ABF and PetCO2. If the results are confirmed with further studies, rapid variations of PetCO2 during anesthesia may provide a noninvasive means of assessing the quality of global tissue perfusion.